Back to Search
Start Over
Helicobacter pylori resistance in Hainan Province, China: investigating phenotypes and genotypes through whole-genome sequencing.
- Source :
-
Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2024 Dec 17; Vol. 14, pp. 1505166. Date of Electronic Publication: 2024 Dec 17 (Print Publication: 2024). - Publication Year :
- 2024
-
Abstract
- Helicobacter pylori is increasingly resistant to antibiotics, significantly lowering eradication rates and posing a major public health challenge. This study investigated the distribution of antibiotic-resistant phenotypes and genotypes of H. pylori in Hainan Province. It determined the minimum inhibitory concentrations (MICs) of six antibiotics using the E-test method and detected resistance genes via Sanger sequencing. Furthermore, we compared resistance detection based on phenotypic analysis and whole genome sequencing (WGS) across 19 clinical isolates of H. pylori . A total of 140 H. pylori strains were isolated. The resistance rates to levofloxacin (LEV), clarithromycin (CLA), and metronidazole (MTZ) were 37.9%, 40.0%, and 93.6%, respectively. Notably, only 3.3% of the strains were susceptible to all six antibiotics. Multidrug-resistant strains accounted for 25.0% of the total, with no resistance detected to amoxicillin (AMX), tetracycline (TET), or furazolidone (FR) during the study period. Genotypic resistance to CLA and LEV showed near-perfect concordance with phenotypic resistance, with Kappa values of 0.910 and 0.938, respectively. Although all isolates were phenotypically sensitive to TET, 16 exhibited a mutation in the 16S rRNA gene (A926G). All strains harboring the R16H/C mutation and truncated rdxA were resistant to metronidazole, demonstrating a specificity of 100%. Therefore, FR, AMX, and TET are recommended as suitable empirical treatment options for H. pylori infections in this region. Genotypic analysis provides a reliable method for predicting resistance to CLA and LEV. WGS proves to be a valuable tool for identifying novel resistance loci in H. pylori and contributes to the phylogenetic classification of strains.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2024 Lv, Li, Zhang, Chen, Chen, Wang, Yang, Gao, Zeng, Xiong, Huang, Huang, Zhang, Chen and Bai.)
- Subjects :
- Humans
China epidemiology
Drug Resistance, Bacterial genetics
Male
Middle Aged
Female
Adult
Genome, Bacterial genetics
Drug Resistance, Multiple, Bacterial genetics
Aged
Metronidazole pharmacology
Young Adult
Adolescent
Clarithromycin pharmacology
Helicobacter pylori genetics
Helicobacter pylori drug effects
Helicobacter pylori isolation & purification
Whole Genome Sequencing
Microbial Sensitivity Tests
Helicobacter Infections microbiology
Anti-Bacterial Agents pharmacology
Genotype
Phenotype
Subjects
Details
- Language :
- English
- ISSN :
- 2235-2988
- Volume :
- 14
- Database :
- MEDLINE
- Journal :
- Frontiers in cellular and infection microbiology
- Publication Type :
- Academic Journal
- Accession number :
- 39742338
- Full Text :
- https://doi.org/10.3389/fcimb.2024.1505166